Adverse Incident Reporting: Palivizumab (Synagis®)

If a patient experiences an adverse event following immunization, please complete the appropriate Adverse Events Following Immunization (AEFI) Form. All forms and questions should be directed to your nearest public health office.

The AEFI Reporting Form and the Guide to Completion and Submission of AEFI Reports can be found on the Health Canada website. 

For more information please contact:

Dept. of Health and Wellness
Barrington Tower, 4th Floor
1894 Barrington Street
P.O. Box 488
Halifax, NS  B3J 2A8
Phone: 902-424-6567
Fax: 902-424-0550

Web Site: Government of Nova Scotia, Communicable Disease Prevention and Control

The IWK Health will request a report from Health Canada on any adverse reactions within Canada during the previous RSV season and review this information with the palivizumab working group annually.